• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of December 5, 2012

  • Print
  • Share
  • E-mail
-

Product Detail

Product Description Source Plasma
Recall Number B-0092-13
Classification Class II
Code Info 0120670922; 0120670420; 0120669623; 0120669233; 0120668631; 0120666057; 0120664300; 0120663873; 0120662673; 0120661633; 0120660951; 0120660581; 0120660044; 0120659556; 0120658867; 0120658422; 0120657338; 0120657046; 0120656310; 0120655992; 0120651739; 0120651008; 0120650195; 0120649474; 0120648612; 0120648062; 0120647087; 0120646615; 0120645595; 0120645206; 0120644218; 0120643550; 0120637632; 0120635366; 0120634217; 0120633574; 0120632409; 0120631978; 0120630408; 0120629596; 0120628386; 0120627877; 0120626800; 0120626336; 0120624193; 0120623705; 0120622656; 0120622229; 0120621101; 0120620702; 0120619738; 0120619204; 0120618173; 0120617647; 0120616569; 0120615589; 0120614950; 0120614086; 0120613388; 0120611482; 0120611242.
Product Distributed Qty 61 Units
Reason For Recall Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.

Event Detail

Event Id 55396
Product Type Biologics
Status Terminated
Recalling Firm CSL Plasma, Inc.
City Lawrence
State KS
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2010-01-12
Initial Firm Notification of Consignee or Public Other
Distribution Pattern Illinois; Germany; Switzerland
-
-